Study finds depression can reduce survival among women with breast cancer
New research from New Mexico State University shows depression can reduce survival rates among American women diagnosed with breast cancer.
Jul 26, 2024
0
0
New research from New Mexico State University shows depression can reduce survival rates among American women diagnosed with breast cancer.
Jul 26, 2024
0
0
Artificial intelligence is being used in a wide variety of applications in medicine, and now scientists have developed an AI system that can boost detection rates for cancerous and precancerous lesions of the esophagus, which ...
A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma models—all without showing signs of toxicity.
Aug 2, 2024
0
58
Two reduced dose radiopharmaceutical therapy approaches for advanced stage metastatic castrate-resistant prostate cancer have been shown to be just as effective as the standard dose, according to new research published in ...
Jul 24, 2024
0
0
People looking to slow or reverse the symptoms of aging can find remedies ranging from restricted diets and ice baths to an alphabet soup of vitamins.
Aug 1, 2024
0
9
A new research paper titled "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma" ...
Jul 15, 2024
0
0
Since the first immunotherapy drug to boost the body's immune response against advanced lung cancer was introduced in the United States in 2015, survival rates of patients with the disease have improved significantly. That's ...
Aug 5, 2024
0
1
Second- or third-line treatment with tisotumab vedotin is efficacious for patients with recurrent cervical cancer, according to a study published in the New England Journal of Medicine.
Jul 8, 2024
0
0
A new approach to treating the most malignant type of brain cancer—glioblastoma—has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates beyond 18 months.
Jul 9, 2024
0
1
Most prostate cancer outcomes do not differ significantly between transgender women (TGW) and cisgender (CG) men, including prostate cancer-specific mortality, according to a study published online July 21 in Cancer.
Jul 26, 2024
0
5